BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 24249700)

  • 1. GBV-C viremia and clinical events in advanced HIV infection.
    Sahni H; Kirkwood K; Kyriakides TC; Stapleton J; Brown ST; Holodniy M;
    J Med Virol; 2014 Mar; 86(3):426-32. PubMed ID: 24249700
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical impact of GB virus C viremia on patients with HIV type 1 infection in the era of highly active antiretroviral therapy.
    Sheng WH; Hung CC; Wu RJ; Wang JT; Chen PJ; Chang SC; Kao JH
    Clin Infect Dis; 2007 Feb; 44(4):584-90. PubMed ID: 17243064
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of early and late GB virus C viraemia on survival of HIV-infected individuals: a meta-analysis.
    Zhang W; Chaloner K; Tillmann HL; Williams CF; Stapleton JT
    HIV Med; 2006 Apr; 7(3):173-80. PubMed ID: 16494631
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Infection with GB virus C and reduced mortality among HIV-infected patients.
    Tillmann HL; Heiken H; Knapik-Botor A; Heringlake S; Ockenga J; Wilber JC; Goergen B; Detmer J; McMorrow M; Stoll M; Schmidt RE; Manns MP
    N Engl J Med; 2001 Sep; 345(10):715-24. PubMed ID: 11547740
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of GBV-C infection in HIV-1 infected patients.
    Canducci F; Uberti Foppa C; Boeri E; Racca S; Gallotta G; Grasso MA; Calori G; Lazzarin A; Clementi M
    J Biol Regul Homeost Agents; 2003; 17(2):191-4. PubMed ID: 14518722
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence and distribution of the GBV-C/HGV among HIV-1-infected patients under anti-retroviral therapy.
    Alcalde R; Nishiya A; Casseb J; Inocêncio L; Fonseca LA; Duarte AJ
    Virus Res; 2010 Aug; 151(2):148-52. PubMed ID: 20420864
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of GB virus type C in urban Americans infected with human immunodeficiency virus type 1.
    Smith SM; Donio MJ; Singh M; Fallon JP; Jitendranath L; Chkrebtii N; Slim J; Finkel D; Perez G
    Retrovirology; 2005 May; 2():38. PubMed ID: 15927079
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Frequency and genotype of GB virus C among Iranian patients infected with HIV.
    Hekmat S; Mohraz M; Vahabpour R; Jam S; Bahramali G; Banifazl M; Aghakhani A; Eslamifar A; Mahboudi F; Edalat R; Ramezani A
    J Med Virol; 2008 Nov; 80(11):1941-6. PubMed ID: 18814233
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of hepatitis G virus (GB virus C) on the prognosis of HIV-infected women.
    Campos AF; Tengan FM; Silva SA; Levi JE
    Int J STD AIDS; 2011 Apr; 22(4):209-13. PubMed ID: 21515753
    [TBL] [Abstract][Full Text] [Related]  

  • 10. GB virus C and HIV-1 RNA load in single virus and co-infected West African individuals.
    Li C; Collini P; Danso K; Owusu-Ofori S; Dompreh A; Candotti D; Opare-Sem O; Allain JP
    AIDS; 2006 Feb; 20(3):379-86. PubMed ID: 16439871
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Persistent GB virus C infection and survival in HIV-infected men.
    Williams CF; Klinzman D; Yamashita TE; Xiang J; Polgreen PM; Rinaldo C; Liu C; Phair J; Margolick JB; Zdunek D; Hess G; Stapleton JT
    N Engl J Med; 2004 Mar; 350(10):981-90. PubMed ID: 14999110
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduced mother-to-child transmission of HIV associated with infant but not maternal GB virus C infection.
    Supapol WB; Remis RS; Raboud J; Millson M; Tappero J; Kaul R; Kulkarni P; McConnell MS; Mock PA; Culnane M; McNicholl J; Roongpisuthipong A; Chotpitayasunondh T; Shaffer N; Butera S
    J Infect Dis; 2008 May; 197(10):1369-77. PubMed ID: 18419578
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of GB virus C on response to antiretroviral therapy in HIV-infected Brazilians.
    Souza IE; Zhang W; Diaz RS; Chaloner K; Klinzman D; Stapleton JT
    HIV Med; 2006 Jan; 7(1):25-31. PubMed ID: 16313289
    [TBL] [Abstract][Full Text] [Related]  

  • 14. No association between GB virus-C viremia and virological or immunological failure after starting initial antiretroviral therapy.
    Brumme ZL; Chan KJ; Dong WW; Mo T; Wynhoven B; Hogg RS; Montaner JS; O'Shaughnessy MV; Harrigan PR
    AIDS; 2002 Sep; 16(14):1929-33. PubMed ID: 12351953
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acquisition of GB virus type C and lower mortality in patients with advanced HIV disease.
    Vahidnia F; Petersen M; Stapleton JT; Rutherford GW; Busch M; Custer B
    Clin Infect Dis; 2012 Oct; 55(7):1012-9. PubMed ID: 22752515
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of primer selection on estimates of GB virus C (GBV-C) prevalence and response to antiretroviral therapy for optimal testing for GBV-C viremia.
    Souza IE; Allen JB; Xiang J; Klinzman D; Diaz R; Zhang S; Chaloner K; Zdunek D; Hess G; Williams CF; Benning L; Stapleton JT
    J Clin Microbiol; 2006 Sep; 44(9):3105-13. PubMed ID: 16954234
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of coinfection with GB virus C on survival among patients with HIV infection.
    Xiang J; Wünschmann S; Diekema DJ; Klinzman D; Patrick KD; George SL; Stapleton JT
    N Engl J Med; 2001 Sep; 345(10):707-14. PubMed ID: 11547739
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [GB virus C: lack of association with transaminases levels, CD4 and HIV viral load in aids patients].
    López Calvo S; Vela A; Castro A; Cid A; Aguilera A; Vega P; Hermida M; Regueiro BJ; Pedreira JD
    An Med Interna; 2003 Apr; 20(4):175-8. PubMed ID: 12768829
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of GB virus C viraemia on clinical outcome in HIV-1-infected patients: a 20-year follow-up study.
    Ernst D; Greer M; Akmatova R; Pischke S; Wedemeyer H; Heiken H; Tillmann HL; Schmidt RE; Stoll M
    HIV Med; 2014 Apr; 15(4):245-50. PubMed ID: 24118889
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Response to HAART and GB virus type C coinfection in a cohort of antiretroviral-naive HIV-infected individuals.
    Antonucci G; Girardi E; Cozzi-Lepri A; Capobianchi MR; Morsica G; Pizzaferri P; Ladisa N; Sighinolfi L; Chiodera A; Solmone M; Lalle E; Ippolito G; Monforte Ad; ;
    Antivir Ther; 2005; 10(1):109-17. PubMed ID: 15751768
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.